Table: Pharmarise Holdings -2023/24 group results

Pharmarise Holdings

28/06/2024 09:00

Jun 28 (Reuters)- 
          Pharmarise Holdings Corp 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                May 31, 2024    May 31, 2023   May 31, 2025     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             54.47           52.03          60.88        30.54    
                 (+4.7 pct)      (+0.8 pct)     (+11.8 pct)  (+13.3 pct) 
  Operating        916 mln           1.44         949 mln      483 mln   
                 (-36.3 pct)     (-5.4 pct)     (+3.6 pct)   (-32.0 pct) 
  Recurring        833 mln           1.43         804 mln      428 mln   
                 (-41.8 pct)     (-5.7 pct)     (-3.4 pct)   (-38.9 pct) 
  Net
  Net           loss 351 mln       333 mln        40 mln        31 mln   
                                 (-25.6 pct)                 (-88.6 pct) 
  EPS          loss 33.41 yen     35.45 yen      3.63 yen      2.77 yen  
  EPS Diluted                     26.90 yen                              
  Ann Div         20.00 yen       14.00 yen      14.00 yen               
  -Q2 Div            NIL             NIL            NIL                  
  -Q4 Div         20.00 yen       14.00 yen      14.00 yen               
  
  NOTE - Pharmarise Holdings Corp.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T